(Q48597156)

13 February 2018

title

Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in mice (English)

1 reference

13 February 2018

0 references

1 reference

A Boireau

1

1 reference

13 February 2018

F Bordier

2

1 reference

13 February 2018

P Dubédat

3

1 reference

13 February 2018

C Pény

4

1 reference

13 February 2018

A Impérato

5

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 October 1997

1 reference

13 February 2018

published in

Neuroscience Letters

1 reference

13 February 2018

volume

234

1 reference

13 February 2018

issue

2-3

1 reference

13 February 2018

page(s)

123-126

1 reference

13 February 2018

Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900685-X

7 January 2021

NMDA antagonists partially protect against MPTP induced neurotoxicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900685-X

7 January 2021

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900685-X

7 January 2021

Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900685-X

7 January 2021

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900685-X

7 January 2021

Clonidine suppresses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced reductions of striatal dopamine and tyrosine hydroxylase activity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900685-X

7 January 2021

Altered brain metabolism of iron as a cause of neurodegenerative diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900685-X

7 January 2021

Cicaprost and the type IV phosphodiesterase inhibitor, rolipram, synergize in suppression of tumor necrosis factor-alpha synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900685-X

7 January 2021

Inhibitors of Type IV Phosphodiesterases Reduce the Toxicity of MPTP in Substantia Nigra NeuronsIn Vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900685-X

7 January 2021

Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900685-X

7 January 2021

The novel anticonvulsant lamotrigine prevents dopamine depletion in C57 black mice in the MPTP animal model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900685-X

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900685-X

7 January 2021

Protection against acute MPTP-induced dopamine depletion in mice by adenosine A1 agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900685-X

7 January 2021

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900685-X

7 January 2021

Diphenylhydantoin and phenobarbital suppress the dopaminergic neurotoxicity of MPTP in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900685-X

7 January 2021

Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900685-X

7 January 2021

Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900685-X

7 January 2021

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900685-X

7 January 2021

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900685-X

7 January 2021

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900685-X

7 January 2021

Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900685-X

7 January 2021

Partial protective effect of MK-801 on MPTP-induced reduction of striatal dopamine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2897%2900685-X

7 January 2021

10.1016/S0304-3940(97)00685-X

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018